Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$910,236
+$488,630 QoQ
Shares Held
67,375
+99.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Graham Capital Management, L.P. holds $5,287,451 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
67,375 | $910,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
951 | $563,923 | |
| 3 | ZTS |
Zoetis Inc.
|
4,736 | $559,842 | |
| 4 | HLN |
Haleon plc
|
48,255 | $483,032 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
84,095 | $454,113 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
6,701 | $397,168 | |
| 7 | AKBA |
Akebia Therapeutics, Inc.
|
248,352 | $345,209 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
9,986 | $330,237 |
All Filings in VTRS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $910,236 | 67,375 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $421,606 | 33,864 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||